By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS


Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte 

Maxygen, Inc. 

Intergen Company 





Company News
Novo Nordisk A/S (NVO)'s $225 Million Hemophilia Facility Will Create 100 New Jobs 5/4/2015 7:27:34 AM
Novo Nordisk A/S (NVO) CEO Candidate Abruptly Departs and Company Starts Hunt Afresh 4/30/2015 6:01:39 AM
Novo Nordisk A/S (NVO) Announces Saxenda (Liraglutide [Rdna Origin] Injection) Is Now Commercially Available In The United States 4/22/2015 11:29:43 AM
Novo Nordisk A/S (NVO) Celebrates World Hemophilia Day And Shares New Support Programs, Including HeroPath And Career Counseling 4/17/2015 10:34:45 AM
Novo Nordisk A/S (NVO) Extends Programme For Children With Diabetes In Developing Countries 4/15/2015 2:13:16 PM
Novo Nordisk A/S (NVO) Soars on Plans to Resubmit NDAs of Tresiba and Ryzodeg in U.S. 3/27/2015 7:18:30 AM
Bristol-Myers Squibb (BMY) Acquires Exclusive License From Novo Nordisk A/S (NVO) For A Discovery Research Program Focused On Autoimmune Diseases 3/24/2015 10:37:29 AM
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015 10:08:01 AM
Novo Nordisk A/S (NVO) Release: New Data In Adults With Obesity Or Who Are Overweight With Comorbidities Losing At Least 5% Body Weight With Saxenda (liraglutide [rDNA origin] injection) Showed Improvement In Blood Glucose, CV Risk Factors And Quality Of Life Outcomes 3/9/2015 6:38:22 AM
Novo Nordisk A/S (NVO) Named On The 2015 FORTUNE 100 Best Companies To Work For List For Seventh Consecutive Year 3/5/2015 12:02:36 PM
12345678910...
//-->